Matches in Wikidata for { <http://www.wikidata.org/entity/Q91264167> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q91264167 description "article scientifique publié en 2018" @default.
- Q91264167 description "artículu científicu espublizáu n'agostu de 2018" @default.
- Q91264167 description "im August 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91264167 description "scientific article published on 01 August 2018" @default.
- Q91264167 description "wetenschappelijk artikel" @default.
- Q91264167 description "наукова стаття, опублікована в серпні 2018" @default.
- Q91264167 name "Expert opinion on the metabolic complications of new anticancer therapies: Tyrosine kinase inhibitors" @default.
- Q91264167 name "Expert opinion on the metabolic complications of new anticancer therapies: Tyrosine kinase inhibitors" @default.
- Q91264167 type Item @default.
- Q91264167 label "Expert opinion on the metabolic complications of new anticancer therapies: Tyrosine kinase inhibitors" @default.
- Q91264167 label "Expert opinion on the metabolic complications of new anticancer therapies: Tyrosine kinase inhibitors" @default.
- Q91264167 prefLabel "Expert opinion on the metabolic complications of new anticancer therapies: Tyrosine kinase inhibitors" @default.
- Q91264167 prefLabel "Expert opinion on the metabolic complications of new anticancer therapies: Tyrosine kinase inhibitors" @default.
- Q91264167 P1433 Q91264167-44D0A5D5-C276-4174-B7B7-21E7438D0A8B @default.
- Q91264167 P1476 Q91264167-21463A7E-8BAE-43FE-9553-8870A540FCFC @default.
- Q91264167 P2093 Q91264167-02C19384-9179-433D-B6C2-99CCEF32FB84 @default.
- Q91264167 P2093 Q91264167-2EE63FE2-246C-4B8E-BD80-BA0C29F70D68 @default.
- Q91264167 P2093 Q91264167-4C84EDB4-D48F-4085-9235-94CD12A172B3 @default.
- Q91264167 P2093 Q91264167-7F3BEF1E-DBCD-442B-8A18-12A865BD2F47 @default.
- Q91264167 P2093 Q91264167-83E9C20A-43A1-4F54-A6F6-D620899D5C35 @default.
- Q91264167 P2093 Q91264167-D61F909D-44FA-4AA9-AAA6-6415506C5E23 @default.
- Q91264167 P2860 Q91264167-F411A366-3DC8-4B9F-8F40-F4072D702EFB @default.
- Q91264167 P304 Q91264167-33B3082B-E6A7-4E41-A830-773EF27C3FEC @default.
- Q91264167 P31 Q91264167-80FE4852-A4AB-4668-9EE4-AA27FA3261F2 @default.
- Q91264167 P356 Q91264167-1608CE1B-692D-450A-A7F0-F3EC09B93E50 @default.
- Q91264167 P433 Q91264167-7CAE5E8A-7658-480B-8530-43215A5C2930 @default.
- Q91264167 P478 Q91264167-C0C1B806-CCEA-4FAD-ABCC-CFBB455571CD @default.
- Q91264167 P577 Q91264167-CCEA127A-EA1B-413A-BC7F-A6EEA5E2899B @default.
- Q91264167 P698 Q91264167-B886DDCE-16E9-47BD-939E-87D760EC7757 @default.
- Q91264167 P356 J.ANDO.2018.07.011 @default.
- Q91264167 P698 30174137 @default.
- Q91264167 P1433 Q15753551 @default.
- Q91264167 P1476 "Expert opinion on the metabolic complications of new anticancer therapies: Tyrosine kinase inhibitors" @default.
- Q91264167 P2093 "Benjamin Bouillet" @default.
- Q91264167 P2093 "Bertrand Cariou" @default.
- Q91264167 P2093 "Bruno Verges" @default.
- Q91264167 P2093 "Francoise Archambeaud" @default.
- Q91264167 P2093 "Perrine Buffier" @default.
- Q91264167 P2093 "Sarra Smati" @default.
- Q91264167 P2860 Q37429236 @default.
- Q91264167 P304 "574-582" @default.
- Q91264167 P31 Q13442814 @default.
- Q91264167 P356 "10.1016/J.ANDO.2018.07.011" @default.
- Q91264167 P433 "5" @default.
- Q91264167 P478 "79" @default.
- Q91264167 P577 "2018-08-01T00:00:00Z" @default.
- Q91264167 P698 "30174137" @default.